Abstract

FOR A COUNTRY that fancies itself an emerging world power backed by thousands of years of history, China has a poor record in the pharmaceutical realm. It hasn't yet brought to market a single one of the major drugs that are sold around the world today. And China's drug industry is far better known for graft and unsafe practices than for its positive achievements. Yet, China's pharmaceutical industry is undergoing a major upgrade. Chinese who have spent decades living abroad are returning in large numbers to inject worldclass practices into the country's pharmaceutical business. This strong dose of talent is complemented by spirited government efforts to build up the R&D capabilities of universities and research institutes. I have confidence that, in the near future, we will have some drugs 100% made in China, says Ningni Yu, the executive in charge of promoting pharmaceutical business activities in Shanghai's Zhangjiang HiTech Park. Yu is well-known among executives ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call